We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Directory of current ICH Guidelines which have been implemented by the Medicines and Healthcare products Regulatory Agency.
We work closely with other governments, international organisations, Parliamentarians, civil society, survivor groups, experts and practitioners from around the world in the fight against sexual violence. Below you can find a selection of these partners.
The MHRA is ready to provide any assistance for clinical trials applications submitted for COVID-19
How to use a case-control study to evaluate your digital health product.
This guidance provides information on COVID-19 in homelessness, domestic abuse refuge, respite room and asylum seeker accommodation settings.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (7 March 2024) approved the medicine rozanolixizumab (Rystiggo) to treat adults with generalised myasthenia gravis, an autoimmune disease that causes muscle weakness, which can affect multiple muscle groups throughout the...
Coronavirus (COVID-19) vaccination consent form and letter templates for healthcare workers.
This collection brings together all documents in the Employment Relations Research Series.
Change your protocol, update your authorisation, report safety issues, submit safety updates and complete your end-of-trial study report.
Military personnel supported public services across the UK to assist with the response to COVID-19.
Guidance for industry on flexible approaches to regulation we are taking during the COVID-19 outbreak.
Information for NHS trusts on the Crown Commercial Service (CCS) health temporary staff frameworks approved by NHS Improvement.
How investigators and sponsors should manage clinical trials during COVID-19
Notifications of COVID-19 and influenza point-of-care testing (POCT) results: legal duties for providers of POCT.
A collection of factsheets, updated guidelines and news stories related to DBS and coronavirus.
How to begin with evaluating a digital health product, including when to evaluate, budgeting and getting support.
The Taskforce was active between 2015 to 2020. This is a collection of documents relating to the Libraries Taskforce.
Guidance on Animal Test Certificates (ATCs) required to carry out the field trial of a veterinary medicine in animals (clinical trial) in the UK.
Information on the role of the Home Office Forensic Pathology Unit and its support of the Pathology Delivery Board.
The Behavioural Insights Limited (BIT) is now fully owned by Nesta. For more information, visit the Behavioural Insights Team website .
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.